These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26713760)

  • 41. Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy.
    Pyatigorskaya N; Yahia-Cherif L; Gaurav R; Ewenczyk C; Gallea C; Valabregue R; Gargouri F; Magnin B; Degos B; Roze E; Bardinet E; Poupon C; Arnulf I; Vidailhet M; Lehericy S
    Mov Disord; 2020 Jan; 35(1):161-170. PubMed ID: 31710146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
    Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
    J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease.
    O'Neill J; Schuff N; Marks WJ; Feiwell R; Aminoff MJ; Weiner MW
    Mov Disord; 2002 Sep; 17(5):917-27. PubMed ID: 12360540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease.
    Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations of diffusion tensor MRI parameters in the brains of patients with Parkinson's disease compared with normal brains: possible diagnostic use.
    Lu CS; Ng SH; Weng YH; Cheng JS; Lin WY; Wai YY; Chen YL; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):3978-3988. PubMed ID: 26945764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.
    Bartzokis G; Cummings JL; Markham CH; Marmarelis PZ; Treciokas LJ; Tishler TA; Marder SR; Mintz J
    Magn Reson Imaging; 1999 Feb; 17(2):213-22. PubMed ID: 10215476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.
    Vaillancourt DE; Spraker MB; Prodoehl J; Abraham I; Corcos DM; Zhou XJ; Comella CL; Little DM
    Neurology; 2009 Apr; 72(16):1378-84. PubMed ID: 19129507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging.
    Sánchez-Castañeda C; Cherubini A; Elifani F; Péran P; Orobello S; Capelli G; Sabatini U; Squitieri F
    Hum Brain Mapp; 2013 Jul; 34(7):1625-35. PubMed ID: 22359398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging.
    Zhan W; Kang GA; Glass GA; Zhang Y; Shirley C; Millin R; Possin KL; Nezamzadeh M; Weiner MW; Marks WJ; Schuff N
    Mov Disord; 2012 Jan; 27(1):90-7. PubMed ID: 21850668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
    PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of high-field magnetic resonance imaging in Parkinson's disease.
    Qiao PF; Shi F; Jiang MF; Gao Y; Niu GM
    Exp Ther Med; 2017 May; 13(5):1665-1670. PubMed ID: 28565751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson's disease.
    Wang J; Yang QX; Sun X; Vesek J; Mosher Z; Vasavada M; Chu J; Kanekar S; Shivkumar V; Venkiteswaran K; Subramanian T
    Parkinsonism Relat Disord; 2015 Jun; 21(6):590-6. PubMed ID: 25825242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lateralized Basal Ganglia Vulnerability to Pesticide Exposure in Asymptomatic Agricultural Workers.
    Lewis MM; Sterling NW; Du G; Lee EY; Shyu G; Goldenberg M; Allen T; Stetter C; Kong L; Snipes SA; Jones BC; Chen H; Mailman RB; Huang X
    Toxicol Sci; 2017 Sep; 159(1):170-178. PubMed ID: 28633499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substantia nigra fractional anisotropy changes confirm the PD at-risk status of patients with idiopathic smell loss.
    Haehner A; Schöpf V; Loureiro A; Linn J; Reichmann H; Hummel T; Kitzler HH
    Parkinsonism Relat Disord; 2018 May; 50():113-116. PubMed ID: 29477459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The usage of proton magnetic resonance spectroscopy in Parkinson's disease.
    Metarugcheep P; Hanchaiphiboolkul S; Viriyavejakul A; Chanyawattiwongs S
    J Med Assoc Thai; 2012 Jul; 95(7):949-52. PubMed ID: 22919991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.